May 19, 2012

Regeneron: FDA panel says no to Arcalyst for gout

Regeneron Pharmaceuticals Inc. said Tuesday that a Food and Drug Administration panel has recommended its drug Arcalyst not be approved as a treatment for gout.

View post:
Regeneron: FDA panel says no to Arcalyst for gout

FDA advisers rebuff Regeneron gout drug

WASHINGTON (Reuters) – U.S.

View the original here:
FDA advisers rebuff Regeneron gout drug

Regeneron Drug Arcalyst To Be Reviewed For Gout Treatment

  Regeneron Pharmaceuticals Inc. announced Tuesday that the Food and Drug Administration has agreed to review its drug Arcalyst as a gout treatment.   The review will be complete by July 30, according to the company

View original post here:
Regeneron Drug Arcalyst To Be Reviewed For Gout Treatment

Tampa Bay Rays pitcher J.P. Howell has gout

By Marc Topkin, Times Staff Writer Friday, June 24, 2011 HOUSTON — As much as his left foot hurt as he walked off the field Tuesday night in Milwaukee, LHP J.P. Howell feared the worst. “I thought it was 4-6 weeks in a boot,” Howell said.

See the original article here:
Tampa Bay Rays pitcher J.P. Howell has gout

U.S. FDA panel rejects Novartis drug for gout

An advisory panel on Tuesday rejected a Novartis AG drug for gout over concerns about side effects, a setback for the company’s efforts to expand use of the medicine.

View original post here:
U.S. FDA panel rejects Novartis drug for gout

FDA panel rejects Novartis drug for gout

A U.S. advisory panel on Tuesday rejected a Novartis AG drug for gout over concerns about side effects, a setback for the company’s efforts to expand use of the medicine.

Link:
FDA panel rejects Novartis drug for gout

Woman appointed as new ProRail boss

Rail network operator ProRail announced on Tuesday it is to appoint Marion Gout-van Sinderen as its new chairwoman. The official announcement will be made on April 11.

More here:
Woman appointed as new ProRail boss

SEO Powered By SEOPressor